You have no items in your shopping cart.
On Promotion 
Tested Applications
Reactivity
Predicted Reactivity
Conjugation
Biologically Active
Featured Product
Human Serpin H1 [orb2994900]Unconjugated
SDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 45.5 KDa. Observed: 51 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg- Human COL8A1 [orb2994859]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 71.6 KDa. Observed: 58&85 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Mouse Endostatin [orb2994725]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 21.2 KDa. Observed: 18 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human COL21A1 [orb2994071]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 97.9 KDa. Observed: 115-125&220 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Mouse GPVI [orb2993762]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 27.8 KDa. Observed: 40-60 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human CTHRC1 [orb2994686]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 24.1 KDa. Observed: 25-30 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Mouse Acrp30 [orb2994586]
Unconjugated
SDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 27.2 KDa. Observed: 30 KDa, reducing conditions
50 μg, 500 μg, 1 mg, 10 μg - Human COL9A1 [orb2994545]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 33.8 KDa. Observed: 38-50 KDa, reducing conditions
1 mg, 10 μg, 50 μg, 500 μg - Mouse Acrp30 [orb2994517]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 25.7 KDa. Observed: 30 KDa, reducing conditions
500 μg, 1 mg, 10 μg, 50 μg 